Lassa fever vaccine is one step closer to approval. Lassa virus infections, primarily spread by rodents, can cause a fatal ...

NIH has launched a human trial for LASSARAB, a dual-purpose vaccine targeting Lassa fever and rabies. Early animal studies ...

Thomas Jefferson University has initiated a phase 1 clinical trial for a Lassa virus (LASV) vaccine developed at Jefferson in collaboration with the University of Maryland, Baltimore (UMB), at the ...

NIH-sponsored trial of candidate vaccine to prevent Lassa fever begins enrolling participants: Bethesda, Maryland Thursday, March 20, 2025, 18:00 Hrs [IST] A National Institutes o ...

NIH-Sponsored Trial of Lassa Vaccine Opens - Viral Hemorrhagic Disease Can be Fatal & Causes Permanent Hearing Loss ...

A National Institutes of Health (NIH)-sponsored clinical trial of a candidate vaccine to prevent Lassa fever has begun enrolling participants at the University of Maryland School of Medicine, ...

According to the Plasma Protein Therapeutics Association (PPTA), plasma is the ... Among them, KEDRAB® – a human rabies immune globulin (HRIG) therapeutic for the treatment of potential rabies ...

Discovered in the state of Ceará, Brazil, the novel coronavirus shares similarities with the virus responsible for Middle East respiratory syndrome, first identified in 2012. Experiments to determine ...

Bavarian Nordic A/S (OMX: BAVA) announced today that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has validated the marketing authorization application and accepted to start the ...

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued stocks in the Pharmaceuticals industry for Monday, March 24, 2025. Let’s take ...